1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 101. Bulkley C F, Johnson P N, Henry E, Harrison D, Lewis T V, Miller J L. Bumetanide continuous-infusion dosing in critically ill pediatric patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012; 69 : 1458, 1460-1
102. Johnson P N, Miller J L, Harrison D. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children. Journal of Pediatric Intensive Care. 2012; 2 : 105-113
103. Johnson P N, Boyles K A, Miller J L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012; 32 : 148-57
104. Miller J L, Nandyal R R, Anderson M P, Escobedo M B. Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infants. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012; 17 : 58-66
105. Miller J L, Nandyal R R, Anderson M, Escobedo M B. Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infants. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012; 17 : 58-66
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.